| |
| |
|
| Insider
Information: |
Johnson Craig A |
| Relationship: |
Director |
| City: |
La Jolla |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
91,395 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$51,418,476 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
91,395 |
|
|
| Total
Value |
$51,418,476 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardea Biosciences Inc |
RDEA |
Director |
2011-08-01 |
0 |
2011-07-01 |
0 |
Premium* |
|
|
Adamis Pharmaceuticals Corp |
ADMP |
Director |
2013-03-06 |
22,575 |
2013-03-06 |
0 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
Director |
2024-01-19 |
65,820 |
|
0 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
|
2024-01-23 |
0 |
2019-01-29 |
0 |
Premium* |
|
|
Odonate Therapeutics Inc |
ODT |
Director |
2020-12-29 |
3,000 |
2020-12-29 |
0 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
Director |
2022-08-22 |
0 |
2022-07-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2011-07-01 |
4 |
OE |
$12.16 |
$24,320 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2011-07-01 |
4 |
AS |
$26.13 |
$52,489 |
D/D |
(2,000) |
0 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2011-08-01 |
4 |
OE |
$12.16 |
$12,160 |
D/D |
1,000 |
1,000 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2011-08-01 |
4 |
AS |
$23.16 |
$23,163 |
D/D |
(1,000) |
0 |
0 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
Director |
– • – |
2013-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
22,575 |
22,575 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2014-01-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
840 |
|
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2020-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,840 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Director |
– • – |
2020-12-29 |
4 |
B |
$17.00 |
$51,000 |
D/D |
3,000 |
3,000 |
2.39 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2021-04-06 |
4 |
AS |
$17.22 |
$4,305 |
D/D |
(250) |
3,590 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2021-06-21 |
4 |
AS |
$15.20 |
$3,801 |
D/D |
(250) |
3,340 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2021-09-21 |
4 |
AS |
$12.30 |
$3,074 |
D/D |
(250) |
3,090 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2021-12-21 |
4 |
AS |
$9.73 |
$2,432 |
D/D |
(250) |
2,840 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2021-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,452 |
13,292 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Director |
– • – |
2022-07-08 |
4 |
OE |
$3.93 |
$47,160 |
D/D |
12,000 |
12,000 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Director |
– • – |
2022-08-22 |
4 |
D |
$6.23 |
$74,760 |
D/D |
(12,000) |
0 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2022-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
38,580 |
51,872 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
Director |
– • – |
2023-12-29 |
4 |
A |
$58.75 |
$399,970 |
D/D |
6,808 |
17,273 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2024-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
13,948 |
65,820 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2019-01-29 |
4 |
OE |
$3.65 |
$147,030 |
D/D |
17,000 |
17,000 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2019-01-29 |
4 |
AS |
$61.11 |
$1,044,773 |
D/D |
(17,000) |
0 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2020-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2020-04-20 |
4 |
AS |
$93.00 |
$1,395,000 |
D/D |
(15,000) |
2,000 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2020-04-20 |
4 |
OE |
$25.84 |
$387,600 |
D/D |
15,000 |
17,000 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,475 |
3,475 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2021-01-21 |
4 |
AS |
$210.01 |
$3,173,203 |
D/D |
(15,000) |
3,475 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
